WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001002031) TARGETED ANTICALCIFICATION TREATMENT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/002031    International Application No.:    PCT/US2000/017606
Publication Date: 11.01.2001 International Filing Date: 27.06.2000
Chapter 2 Demand Filed:    26.01.2001    
IPC:
A61L 27/50 (2006.01)
Applicants: BIOMEDICAL DESIGN, INC. [US/US]; 2161 New Market Parkway, S.E., Suite 214, Marietta, GA 30067-9310 (US)
Inventors: SIMIONESCU, Dan; (US).
SIMIONESCU, Agneta; (RO).
GIRARDOT, Jean-Marie; (US).
GIRARDOT, Marie-Nadia; (US)
Agent: SAMPLES, Kenneth, H.; Fitch, Even, Tabin & Flannery, Suite 1600, 120 South LaSalle, Chicago, IL 60603 (US)
Priority Data:
60/142,171 01.07.1999 US
Title (EN) TARGETED ANTICALCIFICATION TREATMENT
(FR) TRAITEMENT ANTI-CALCIFICATION CIBLE
Abstract: front page image
(EN)Methods for providing biomaterials with increased resistance to calcification by treating with cell-targeted agents and/or with matrix-targeted agents. Cell-targeted agents are used which block calcium channels or which prevent oxidative damage to cells and/or inhibit enzymes. Other treatments of biomaterials may remove cell-derived calcium-binding components or target extracellular matrices, as by cleaving proteins with cyanogen bromide or reducing disulfide bonds to produce sulfhydryl groups which are thereafter alkylated. Combinations of the foregoing different treatments are also effective in increasing the calcification resistance of cardiovascular tissues that were previously subjected to chemical fixing and/or other anticalcification treatments.
(FR)La présente invention concerne des procédés permettant de conférer aux biomatériaux une résistance accrue à la calcification, grâce à un traitement au moyen d'agents à ciblage cellulaire et/ou à ciblage matriciel. En l'occurrence, on utilise des agents à ciblage cellulaire qui bloquent les canaux calcium, ou qui préviennent l'atteinte oxydative des cellules, et/ou qui inhibent des enzymes. D'autres traitements des biomatériaux permettent d'éliminer des composants de liaison au calcaire issus des cellules, ou cibler des matrices extracellulaire, notamment par un clivage de protéines au moyen du bromure de cyanogène, ou par réduction des liaisons bisulfure donnant des groupes sulfhydryles qui sont ensuite alkylés. Différentes combinaisons de ces traitements permettent également d'augmenter la résistance à la calcification de tissus cardio-vasculaires ayant préalablement subi des traitements de fixation chimique ou d'anti-calcification.
Designated States: AU, CA, JP.
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: English (EN)
Filing Language: English (EN)